| [1] |
Capper D, Gaiser T, Hartmann C, et al. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation[J]. Acta Neuropathol,2009,11 7( 4):445-56.
|
| [2] |
Frank S, Köhler U, Schackert G, et al. Expression of TRAIL and its receptors in human brain tumors[J]. Biochem Biophys Res Commun,1999,257(2):454-9.
|
| [3] |
Thorburn A. Tumor necrosis factor-related apoptosisinducing ligand (TRAIL) pathway signaling[J]. J Thorac Oncol,2007,2(6):461-5.
|
| [4] |
Abdulghani J, El-Deiry WS. TRAIL receptor signaling and therapeutics[J]. Expert Opin Ther Targets,2010,14(10):1091-108.
|
| [5] |
Pollack IF, Erff M, Ashkenazi A. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells[J]. Clin Cancer Res,2001,7(5):1362-9.
|
| [6] |
Perlstein B, Finniss SA, Miller C, et al. TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo[J]. Neuro Oncol,2013,15(1):29-40.
|
| [7] |
Ehtesham M, Kabos P, Gutierrez MA, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand[J]. Cancer Res,2002, 62(24):7170-4.
|
| [8] |
Shah K, Bureau E, Kim DE, et al. Glioma therapy and realtime imaging of neural precursor cell migration and tumor regression[J]. Ann Neurol,2005,57(1):34-41.
|
| [9] |
Germano IM, Uzzaman M, Benveniste RJ, et al. Apoptosis in human glioblastoma cells produced using embryonic stem cellderived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand[J]. J Neurosurg,2006,105(1):88-95.
|
| [10] |
Uzzaman M, Keller G, Germano IM. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas[J]. Neuro Oncol,2009,11(2):102-8.
|
| [11] |
Fan CG, Zhang QJ. Application prospect of bone marrow mesenchymal stem cells in the treatment of glioma[J]. Zhongguo Zu Zhi Gong Cheng Yan Jiu,2012,16(41):7737-41. [范存刚, 张庆 俊. 骨髓间充质干细胞在脑胶质瘤治疗中的应用前景[J].中国 组织工程研究,2012,16(41),7737-41.]
|
| [12] |
Sasportas LS, Kasmieh R, Wakimoto H, et al. Assessment of therapeutic effi cacy and fate of engineered human mesenchymal stem cells for cancer therapy[J]. Proc Natl Acad Sci U S A,2009,106(12):4822-7.
|
| [13] |
Menon LG, Kelly K, Yang HW, et al. Human bone marrowderived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy[J]. Stem Cells,2009,27(9):2320-30.
|
| [14] |
Yang B, Wu X, Mao Y, et al. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells[J]. Neurosurgery,2009,65(3):610- 24.
|
| [15] |
Fan CG, Zhou JR, Zhang QJ. The application prospects of human umbilical cord blood derived mesenchymal stem cells in brain glioma[J]. Guo Ji Shen Jing Bing Xue Shen Jing Wai Ke Xue Za Zhi, 2011,38(6):598-602. [范存刚, 周景儒, 张庆俊. 人脐带血来 源的间充质干细胞在脑胶质瘤治疗中的应用前景[J]. 国际神经 病学神经外科学杂志,2011,38(6), 598-602.]
|
| [16] |
Kim SM, Lim JY, Park SI, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma [J]. Cancer Res,2008,68(23):9614-23.
|
| [17] |
Kim SM, Oh JH, Park SA, et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord bloodderived mesenchymal stem cells in glioma therapy[J]. Stem Cells,2010,28(12):2217-28.
|
| [18] |
Fan CG, Zhang QJ. The potentials of human adipose tissue derived mesenchymal stem cells in targeted therapy of experimental glioma[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi,2012,12(6):651-4. [范存刚, 张庆俊. 人脂肪源性间充质干细 胞在实验性脑胶质瘤靶向治疗中的应用[J]. 中国现代神经疾病 杂志,2012,12(6),651-4.]
|
| [19] |
Choi SA, Hwang SK, Wang KC, et al. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma[J]. Neuro Oncol,2011,13(1):61-9.
|
| [20] |
Fan CG, Wang DL, Zhang QJ,et al. The experimental investigation of glioma-trophic capacity of human umbilical cord-derived mesenchymal stem cells after intraventricular administration[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2013,13(7),620-7. [范存刚,王栋梁,张庆俊,等. 经侧脑室注射人脐带间充质干 细胞向胶质瘤趋化能力的实验研究[J]. 中国现代神经疾病杂 志,2013,13(7),620-7.]
|
| [21] |
Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord[J]. Stem Cell Rev,2011,7(1):195-207.
|
| [22] |
Unterkircher T, Cristofanon S, Vellanki SH, et al. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis[J]. Clin Cancer Res,2011,17(12):4019-30.
|
| [23] |
Balyasnikova IV, Ferguson SD, Han Y, et al. Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts[J]. Cancer Lett,2011,310(2):148-59.
|
| [24] |
Kahana S, Finniss S, Cazacu S, et al. Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions[J]. Cell Signal,2011,23(8):1348-57.
|
| [25] |
Ding L, Yuan C, Wei F, et al. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP[J]. Cancer Invest,2011,29( 8) :511-20.
|
| [26] |
Qiu B, Sun X, Zhang D, et al. TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro[J]. Int J Mol Sci,2012,13(7):9142-56.
|
| [27] |
Hingtgen S, Ren X, Terwilliger E, et al. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide[J]. Mol Cancer Ther,2008,7(11):3575-85.
|
| [28] |
Yulyana Y, Endaya BB, Ng WH, et al. Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma[J]. Stem Cells Dev,2013,22(13): 18 70-82.
|
| [29] |
Corsten MF, Miranda R, Kasmieh R, et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas[J]. Cancer Res,2007,67(19):8994-9000.
|
| [30] |
Bagci-Onder T, Wakimoto H, Anderegg M, et al. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem celldelivered TRAIL in experimental glioma models[J]. Cancer Res,2011,71(1):154-63.
|
| [31] |
van de Water JA, Bagci-Onder T, Agarwal AS, et al. Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects[J]. Proc Natl Acad Sci U S A,2012,109(41):16642-7.
|
下载:
